Contrarily, Lin et al. and Zeestraten et al. did not show statistically significant associations between tumour HLA-G expression and clinical patient outcome, despite considerably diverging percentages of HLA-G-expressing tumour samples (71 vs. 20%, respectively) [26,30]. This evidence concerns the gene HLA-G and neoplasm.